SITC Cancer Immunotherapy Guidelines – Bladder Carcinoma

The first evidence-based consensus statement on tumor immunotherapy for the treatment of patients with bladder cancer was developed by the Society for Immunotherapy of Cancer (SITC) and published online by the Journal for ImmunoTherapy of Cancer, in 2017.

Immunotherapeutic drugs approved for the treatment of bladder cancer include several checkpoint inhibitors and the immunotherapeutic vaccine, Bacillus Calmette-Guérin (BCG). This consensus statement provides expert evidence-based recommendations for the use of these immunotherapies, including recommendations for patient selection, toxicity management, clinical end points and sequencing or combination of therapies.

Current Guideline

up-to-Date

Published Aug. 15, 2017 in the Journal for ImmunoTherapy of Cancer (JITC) as "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma."

Pocket Guides

Key points from SITC's Cancer Immunotherapy Guidelines Bladder Carcinoma have been distilled into a Pocket Guide. This condensed, easily accessible version of the full Cancer Immunotherapy Guideline is a quick-reference tool available in both digital and print.

Download SITC's Cancer Immunotherapy Guidelines Bladder Carcinoma Pocket Guide on any desktop or mobile device free today.*

*Available only through the Guideline Central App.

ORDER Digital/Print Guide

Cancer Immunotherapy Guidelines Bladder Carcinoma Subcommittee

Subcommittee Leadership

Ashish Kamat, MD, MBBS, FACS (co-chair)
University of Texas MD Anderson Cancer Center

Jonathan Rosenberg, MD (co-chair)
Memorial Sloan Kettering Cancer Center

Subcommittee Members

Prasanth Abraham, RN
University of Texas MD Anderson Cancer Center

Joaquim Bellmunt, MD
Dana-Farber Cancer Institute

Matthew Galsky, MD
Tisch Cancer Institute At Mount Sinai Medical Center

Badri Konety, MD, MBA
University of Minnesota

Donald Lamm, MD, FACS
Bladder Cancer Genitourinary Oncology

David Langham
Bladder Cancer Advocacy Network North Carolina Triangle Chapter

Cheryl Lee, MD
University of Michigan

Matthew Milowsky, MD
University of North Carolina

Mike O’Donnell, MD
University of Iowa

Peter O’Donnell, MD
University of Chicago

Daniel Petrylak, MD
Yale Cancer Center

Padmanee Sharma, MD, PhD
University of Texas MD Anderson Cancer Center

Eila Skinner, MD
Stanford University

Guru Sonpavde, MD
University of Alabama

John Taylor III, MD
University of Connecticut